166 related articles for article (PubMed ID: 29704994)
1. γH2AX is increased in peripheral blood lymphocytes of Alzheimer's disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging.
Siddiqui MS; Francois M; Hecker J; Faunt J; Fenech MF; Leifert WR
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():6-18. PubMed ID: 29704994
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing.
Siddiqui MS; Francois M; Rainey-Smith S; Martins R; Masters CL; Ames D; Rowe CC; Macaulay LS; Fenech MF; Leifert WR
Life (Basel); 2020 Aug; 10(8):. PubMed ID: 32781776
[TBL] [Abstract][Full Text] [Related]
3. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians.
Lee SL; Thomas P; Hecker J; Faunt J; Fenech M
Environ Mol Mutagen; 2015 Jan; 56(1):32-40. PubMed ID: 25099033
[TBL] [Abstract][Full Text] [Related]
5. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
7. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
8. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
9. Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease.
Shanbhag NM; Evans MD; Mao W; Nana AL; Seeley WW; Adame A; Rissman RA; Masliah E; Mucke L
Acta Neuropathol Commun; 2019 May; 7(1):77. PubMed ID: 31101070
[TBL] [Abstract][Full Text] [Related]
10. Guanine-quadruplexes are increased in mild cognitive impairment and correlate with cognitive function and chromosomal DNA damage.
François M; Leifert WR; Hecker J; Faunt J; Fenech MF
DNA Repair (Amst); 2016 Oct; 46():29-36. PubMed ID: 27522611
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
13. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
14. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.
François M; Leifert W; Hecker J; Faunt J; Martins R; Thomas P; Fenech M
Cytometry A; 2014 Aug; 85(8):698-708. PubMed ID: 24616437
[TBL] [Abstract][Full Text] [Related]
15. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
16. γH2AX responses in human buccal cells exposed to ionizing radiation.
Siddiqui MS; François M; Fenech MF; Leifert WR
Cytometry A; 2015 Apr; 87(4):296-308. PubMed ID: 25515017
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease.
Vasantharekha R; Priyanka HP; Swarnalingam T; Srinivasan AV; ThyagaRajan S
Geriatr Gerontol Int; 2017 Oct; 17(10):1737-1745. PubMed ID: 27921357
[TBL] [Abstract][Full Text] [Related]
18. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease.
Choi J; Lee HW; Suk K
J Neurol; 2011 Dec; 258(12):2181-5. PubMed ID: 21562723
[TBL] [Abstract][Full Text] [Related]
19. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.
Lu R; Wang J; Tao R; Wang J; Zhu T; Guo W; Sun Y; Li H; Gao Y; Zhang W; Fowler CJ; Li Q; Chen S; Wu Z; Masters CL; Zhong C; Jing N; Wang Y; Wang Y
Mol Psychiatry; 2018 Mar; 23(3):767-776. PubMed ID: 28696436
[TBL] [Abstract][Full Text] [Related]
20. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
